FIELD: medicine.
SUBSTANCE: what is presented is using pentacyclic triterpenoid miliacine as an agent to reduce systemic pathological endotoxinemia accompanying the salmonella infection.
EFFECT: pre-administration of miliacine has provided reducing blood endotoxins in the infected animals and the production of the inflammation mediators IL-6, IL-17, gamma-INF, but increasing the production of the proinflammatory cytokine IL-10; death of the infected animals has been decreased.
2 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| ANTIMUTAGENIC AGENT | 2019 | 
 | RU2698204C1 | 
| METHOD OF PROTECTING POST-VACCINATION IMMUNITY TO TETANUS ANATOXIN AGAINST METHOTREXATE-INDUCED DEPRESSION | 2008 | 
 | RU2394577C1 | 
| MEANS FOR SELECTIVE EFFECT ON BIOFILM FORMATION BY MICROORGANISMS | 2016 | 
 | RU2646488C2 | 
| METHOD FOR DIAGNOSTICS OF LATENT DISEASES BASING ON SYSTEMIC ENDOTOXAMIA INDICES | 2015 | 
 | RU2609763C1 | 
| AGENT LIMITING LYMPHOTOXIN EFFECT OF METHOTREXATE | 2007 | 
 | RU2337693C1 | 
| METHOD FOR COMPLEX CORRECTION OF NON-SCARRING ALOPECIA IN EXPERIMENT | 2023 | 
 | RU2821779C1 | 
| METHOD FOR REDUCING GEMOTOXIC ACTION OF BENZENE ON AN ORGANISM | 2017 | 
 | RU2724891C2 | 
| AGENT ENHANCING IMMUNOGENIC PROPERTY OF TETANUS ANATOXIN | 2003 | 
 | RU2244548C1 | 
| MEDICATION INCREASING NON-SPECIFIC RESISTANCE OF ORGANISM TO BACTERIAL ENDOTOXINS | 2007 | 
 | RU2351351C1 | 
| METHOD FOR TREATMENT OF UBEITIS OF OBSCURE AND VIRAL ETIOLOGY | 2005 | 
 | RU2301672C1 | 
Authors
Dates
2015-10-10—Published
2014-05-07—Filed